全文获取类型
收费全文 | 2383712篇 |
免费 | 177833篇 |
国内免费 | 3417篇 |
专业分类
耳鼻咽喉 | 32386篇 |
儿科学 | 76882篇 |
妇产科学 | 63415篇 |
基础医学 | 352891篇 |
口腔科学 | 64304篇 |
临床医学 | 215778篇 |
内科学 | 464017篇 |
皮肤病学 | 52238篇 |
神经病学 | 188523篇 |
特种医学 | 89474篇 |
外国民族医学 | 489篇 |
外科学 | 359946篇 |
综合类 | 48034篇 |
现状与发展 | 12篇 |
一般理论 | 893篇 |
预防医学 | 186777篇 |
眼科学 | 55127篇 |
药学 | 177870篇 |
12篇 | |
中国医学 | 4608篇 |
肿瘤学 | 131286篇 |
出版年
2021年 | 19711篇 |
2019年 | 20227篇 |
2018年 | 27938篇 |
2017年 | 20971篇 |
2016年 | 23378篇 |
2015年 | 26374篇 |
2014年 | 37237篇 |
2013年 | 55678篇 |
2012年 | 77101篇 |
2011年 | 81883篇 |
2010年 | 48438篇 |
2009年 | 45771篇 |
2008年 | 76827篇 |
2007年 | 81904篇 |
2006年 | 82676篇 |
2005年 | 80108篇 |
2004年 | 76537篇 |
2003年 | 73744篇 |
2002年 | 71302篇 |
2001年 | 109252篇 |
2000年 | 111930篇 |
1999年 | 94006篇 |
1998年 | 27418篇 |
1997年 | 24002篇 |
1996年 | 24411篇 |
1995年 | 23103篇 |
1994年 | 21227篇 |
1993年 | 20008篇 |
1992年 | 72339篇 |
1991年 | 70373篇 |
1990年 | 68689篇 |
1989年 | 65931篇 |
1988年 | 60570篇 |
1987年 | 59362篇 |
1986年 | 55454篇 |
1985年 | 53280篇 |
1984年 | 39566篇 |
1983年 | 33595篇 |
1982年 | 20044篇 |
1979年 | 36041篇 |
1978年 | 25817篇 |
1977年 | 21365篇 |
1976年 | 20465篇 |
1975年 | 21953篇 |
1974年 | 26287篇 |
1973年 | 24939篇 |
1972年 | 23344篇 |
1971年 | 22147篇 |
1970年 | 20371篇 |
1969年 | 19442篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
22.
23.
24.
25.
Troppmair Teresa Egger J. Krösbacher A. Zanvettor A. Schinnerl A. Neumayr A. Baubin M. 《Der Anaesthesist》2022,71(4):272-280
Die Anaesthesiologie - Die Qualität eines Rettungssystems zeichnet sich auch durch den effizienten Einsatz seiner personellen und Fahrzeugressourcen aus. So können im berechtigten Fall... 相似文献
26.
27.
28.
29.
Xiying Fan Glen A. Bjerke Kent Riemondy Li Wang Rui Yi 《Molecular carcinogenesis》2019,58(12):2241-2253
MicroRNAs (miRNAs) play important roles in prostate cancer development. However, it remains unclear how individual miRNAs contribute to the initiation and progression of prostate cancer. Here we show that a basal layer‐enriched miRNA is required for prostate tumorigenesis. We identify miR‐205 as the most highly expressed miRNA and enriched in the basal cells of the prostate. Although miR‐205 is not required for normal prostate development and homeostasis, genetic deletion of miR‐205 in a Pten null tumor model significantly compromises tumor progression and does not promote metastasis. In Pten null basal cells, loss of miR‐205 attenuates pAkt levels and promotes cellular senescence. Furthermore, although overexpression of miR‐205 in prostate cancer cells with luminal phenotypes inhibits cell growth in both human and mouse, miR‐205 has a minimal effect on the growth of a normal human prostate cell line. Taken together, we have provided genetic evidence for a requirement of miR‐205 in the progression of Pten null‐induced prostate cancer. 相似文献
30.
M.-A. Fauroux A. Germa P. Tramini C. Nabet 《Revue d'épidémiologie et de santé publique》2019,67(4):223-231
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France. 相似文献